RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RXRX is currently covered by 4 analysts with an average price target of $7.7. This is a potential upside of $4.59 (147.59%) from yesterday's end of day stock price of $3.11.

Recursion Pharmaceuticals's activity chart (see below) currently has 74 price targets and 71 ratings on display. The stock rating distribution of RXRX is 41.67% BUY and 58.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.74% with an average time for these price targets to be met of 37.64 days.

Highest price target for RXRX is $8, Lowest price target is $5, average price target is $6.

Most recent stock forecast was given by MICHAEL RYSKIN from BAML on 26-Feb-2026. First documented stock forecast 11-May-2021.

Currently out of the existing stock ratings of RXRX, 5 are a BUY (41.67%), 7 are a HOLD (58.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 18-Apr-2022

$6

$2.89 (92.93%)

1 months 9 days ago
(26-Feb-2026)

1/2 (50%)

$2.23 (59.15%)

31

Buy Since 16-Mar-2023

$8

$4.89 (157.23%)

$8

1 months 9 days ago
(26-Feb-2026)

2/23 (8.7%)

$4.23 (112.20%)

71

Hold Since 03-Jul-2025

$5

$1.89 (60.77%)

$4.8

4 months 18 days ago
(17-Nov-2025)

2/3 (66.67%)

$0.88 (21.36%)

3

Hold Since 03-Sep-2024

$5

$1.89 (60.77%)

$8

9 months 1 days ago
(03-Jul-2025)

3/5 (60%)

$-0.27 (-5.12%)

65

Buy Since 16-Sep-2022

$10

$6.89 (221.54%)

$12

1 years 2 months 27 days ago
(08-Jan-2025)

3/9 (33.33%)

$2.74 (37.74%)

36

Show more analysts

Please expand the browser size to see the chart

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 37.64 days on average for the stock forecasts to be realized with a an average price target met ratio 62.74

Which analyst has the current highest performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GIL BLUM

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 32 price targets and 38 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Donald Hooker with highest potential upside - $32.89

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Vikram Purohit with lowest potential downside - $1.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?